RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer
Ontology highlight
ABSTRACT: RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer
PROVIDER: PRJNA578685 | ENA |
REPOSITORIES: ENA
ACCESS DATA